Intermediates and key starting materials (KSMs) sit at the heart of multi-step API synthesis — they are the essential chemical building blocks from which every active pharmaceutical ingredient is constructed. Purity, consistency and reproducibility at this stage flow directly into the safety, efficacy and stability of the finished medicine.
Deep experience in developing and manufacturing these critical materials gives our partners a dependable supply chain — a controlled, regulatory-compliant route from raw input to high-quality API.
Start a ProjectMapping and refining the most efficient, scalable and cost-conscious synthetic pathways for the target API.
Moving processes from bench to clinical and then to commercial scale while preserving reproducibility and batch-to-batch consistency.
Production is carried out in facilities aligned with ICH Q7 Good Manufacturing Practice so that quality remains uniform across every campaign.
In-process and release testing — mass spectrometry, NMR and HPLC — verifies the structure, purity and consistency of each lot.
Modern synthetic methods and process-optimisation tools allow us to produce a broad spectrum of drug intermediates.
Regulatory-grade documentation and characterisation aligned to ICH guidelines, ready for global pharmaceutical submissions.
Purity and consistency at the intermediate stage flow straight through to the safety, efficacy and stability of the finished medicine; we design our workflows so quality is never the variable.